CIPO trademark

AlnylamAct & Design

RegisteredCIPOFigurative markClass 42

"AlnylamAct & Design" is a figurative mark owned by Alnylam Pharmaceuticals, Inc., filed at the CIPO on June 19, 2024. It is registered and covers class 42 (Computer and Scientific Services).

View Alnylam Pharmaceuticals, Inc. portfolioGet this data via the API
Official CIPO record
AlnylamAct & Design trademark as filed
As filed with the CIPO
Status
Registered
Since February 9, 2026
Filed
June 19, 2024
Registered
February 9, 2026
Expires
February 9, 2036
Application no.
2333554
Registration no.
TMA1384470
Office
CIPO
Canadian Intellectual Property Office
Mark type
Figurative mark
1 class
Ownership

Who owns AlnylamAct & Design

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alnylam Pharmaceuticals, Inc.

ALNY · United States

69 trademarks in the portfolioView company

Representative

Macrae & Co.

Macrae & Co.

Goods and services

What the mark covers

The products and services AlnylamAct & Design is filed for, grouped by Nice class.

  • DNA screening for scientific research purposes; DNA screening for forensic research purposes; DNA screening for genetic mutations for scientific research purposes; DNA screening for genetic mutations for forensic research purposes

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Registered
  2. Registration Pending
  3. Advertised; Vol.72 Issue 3708
  4. Approval Notice Sent; APPROVED BY PROGRAM EX200M1
  5. Approved; APPROVED BY PROGRAM EX200M1
  6. Search Recorded
  7. Pre-Assessment Letter Sent; Goods or Services Not Acceptable
  8. Formalized
  9. Created
  10. Filed
FAQ

About AlnylamAct & Design

Who owns the trademark "AlnylamAct & Design"?

The CIPO trademark "AlnylamAct & Design" (application 2333554) is owned by Alnylam Pharmaceuticals, Inc.

What is the status of "AlnylamAct & Design"?

Its status at the CIPO is: registered.

When was "AlnylamAct & Design" registered?

It was registered on February 9, 2026 and is due to expire on February 9, 2036.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AlnylamAct & Design and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019deb47-c1a6-7252-b778-20398ffbc06f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb47-c1a6-7252-b778-20398ffbc06f",
  "object": "trademark",
  "mark_text": "AlnylamAct & Design",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "2333554",
  "filing_date": "2024-06-19",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "Alnylam Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb709-7d9a-70dc-b19d-2c56e8a223b5"
    }
  ]
}